// App-Quantinova.ai

: Residential PM2.5 and greenness may modify the effect of physical activity on lung function

Researchers

Presenter

  • Elaine Fuertes

Principal Investigators

  • Debbie Jarvis

  • Bndicte Jacquemin

  • Josep M Ant

  • Gayan Bowatte

  • Roberto Bono

  • Margareta Emtner

  • Thorarinn Gislason

  • Joachim Heinrich

  • John Henderson

  • Ane Johannessen

  • Nino Knzli

  • Bndicte Leynaert

  • Alessandro Marcon

  • Silvia Pascual

  • Johan Sommar

  • Danielle Vienneau

  • Judith Garcia-Aymerich

Medical Centers

  • ISGlobal, Centre for Research in Environmental Epidemiology,Universitat Pompeu Fabra, CIBER Epidemiología y Salud Pública, Barcelona, Spain

  • Institute of Epidemiology I, Helmholtz Zentrum München - German Research Center for Environmental Health; Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital of Munich (LMU), Neuherberg/Munich, Germany

  • MRC-PHE Centre for Environment and Health, Imperial College London; Department of Population Health and Occupational Diseases, National Heart and Lung Institute, Imperial College London, London, United Kingdom

  • ISGlobal, Centre for Research in Environmental Epidemiology (CREAL); Universitat Pompeu Fabra (UPF); CIBER Epidemiología y Salud Pública (CIBERESP); INSERM, U1168, VIMA: Aging and Chronic Diseases, Epidemiological and Public Health Approaches; Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny le Bretonneux, France, Barcelona, Spain

  • Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Australia

  • Department of Public Health and Pediatrics, University of Turin, Turin, Italy

  • 1. Department of Medical Sciences: Respiratory, Allergy and Sleep research, Uppsala University, Uppsala, Sweden

  • Dept. of Respiratory Medicine and Sleep, Landspitali University Hospital, Reykjavik, Iceland

  • School of Social and Community Medicine, University of Bristol, Bristol,United Kingdom

  • Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway

  • Swiss Tropical Public Health Institute, Basel, Switzerland

  • UMR 1152, Pathophysiology and Epidemiology of Respiratory Diseases, INSERM, University Paris-Diderot, Paris, France

  • Unit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health University of Verona Verona Italy, Verona, Italy

  • Respiratory Department, Galdakao Hospital, OSI Barrualde-Galdakao, Biscay, Spain

  • Occupational and Environmental Medicine, Umea University, Umea, Sweden

  • Department Epidemiology and Public Health, Swiss Tropical and Public Health Institute; University of Basel, Basel, Switzerland

Locations

  • Spain

  • Germany

  • United Kingdom

  • Australia

  • Italy

  • Sweden

  • Iceland

  • Norway

  • Switzerland

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A